These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10897845)
21. National epidemiologic surveillance systems of asbestos-related disease and the exposed workers register. Marinaccio A; Branchi C; Massari S; Scarselli A Med Lav; 2006; 97(3):482-7. PubMed ID: 17009684 [TBL] [Abstract][Full Text] [Related]
22. [A follow-up study of lung function among ex-asbestos workers with and without pleural plaques]. Rui F; De Zotti R; Negro C; Bovenzi M Med Lav; 2004; 95(3):171-9. PubMed ID: 15293373 [TBL] [Abstract][Full Text] [Related]
23. [Health surveillance in workers with a previous exposure to asbestos: a method of retrospective evaluation of exposition]. Todaro A; Bordini L; Rubagotti M; Mensi C; Riboldi L G Ital Med Lav Ergon; 2007; 29(3 Suppl):641-2. PubMed ID: 18409883 [TBL] [Abstract][Full Text] [Related]
24. [Imaging of benign asbestos pleural diseases]. Gevenois PA Rev Mal Respir; 2006 Apr; 23 Suppl 2():4S78-4S80. PubMed ID: 16733404 [No Abstract] [Full Text] [Related]
25. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival]. Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101 [TBL] [Abstract][Full Text] [Related]
26. [Role of endobronchial endoscopic techniques in the detection of bronchial cancer]. Thiberville L Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1263-9. PubMed ID: 10897847 [TBL] [Abstract][Full Text] [Related]
27. Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study. Amati M; Tomasetti M; Scartozzi M; Mariotti L; Alleva R; Pignotti E; Borghi B; Valentino M; Governa M; Neuzil J; Santarelli L Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):163-70. PubMed ID: 18199721 [TBL] [Abstract][Full Text] [Related]
28. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
29. [Consensus Conference "Health surveillance of resident population exposed to tremolite in Local Health Unit 3 territory Lagonegro, PZ". Rome 22-23 February 2005]. Musti M; Bruno C; Cassano F; Caputo A; Cauzillo G; Cavone D; Convertini L; De Blasio A; De Mei B; Marra M; Montagano G; Schettino B; Zona A; Comba P Ann Ist Super Sanita; 2006; 42(4):469-76. PubMed ID: 17361072 [TBL] [Abstract][Full Text] [Related]
30. [Asbestos-related diseases in a population near a fibrous cement factory]. Tarrés J; Abós-Herràndiz R; Albertí C; Martínez-Artés X; Rosell-Murphy M; García-Allas I; Krier I; Castro E; Cantarell G; Gallego M; Orriols R Arch Bronconeumol; 2009 Sep; 45(9):429-34. PubMed ID: 19501947 [TBL] [Abstract][Full Text] [Related]
31. [Factors associated with physicians' under-reporting of asbestos-related bronchopulmonary cancers. Telephone survey conducted among general practitioners and pulmonologists randomly selected in the French region of Provence-Alpes-Côte-d'Azur]. Viau A; Arnaud S; Ferrer S; Iarmacovai G; Saliba ML; Souville M; Verger P Rev Prat; 2008 Dec; 58(19 Suppl):9-16. PubMed ID: 19253786 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis of asbestos-related pleuropolmonary diseases. Governa M; Amati M; Bellis D; Bichisecchi E; Santarelli L Med Lav; 2006; 97(3):463-74. PubMed ID: 17009682 [TBL] [Abstract][Full Text] [Related]
33. [Asbestos as a risk factor for pulmonary diseases]. Szeszenia-Dabrowska N Przegl Lek; 2008; 65 Suppl 2():26-34. PubMed ID: 19621651 [TBL] [Abstract][Full Text] [Related]
34. [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia]. Barbieri PG; Lombardi S; Candela A; Pezzotti C; Binda I Med Lav; 2001; 92(4):249-62. PubMed ID: 11676187 [TBL] [Abstract][Full Text] [Related]
35. Papillary mesothelioma of the peritoneum in the absence of asbestos exposure. Meister T; Birkfellner T; Poremba C; Becker JC; Menzel J; Domschke W; Lerch MM Z Gastroenterol; 2003 Apr; 41(4):329-32. PubMed ID: 12695939 [TBL] [Abstract][Full Text] [Related]
36. Pathological anatomy and molecular pathology. Krismann M; Müller KM; Jaworska M; Johnen G Lung Cancer; 2004 Aug; 45 Suppl 1():S29-33. PubMed ID: 15261430 [TBL] [Abstract][Full Text] [Related]
37. Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma. Scherpereel A; Respir Med; 2007 Jun; 101(6):1265-76. PubMed ID: 17137779 [TBL] [Abstract][Full Text] [Related]
38. Dual digital video-autofluorescence imaging for detection of pre-neoplastic lesions. Lee P; Brokx HA; Postmus PE; Sutedja TG Lung Cancer; 2007 Oct; 58(1):44-9. PubMed ID: 17532537 [TBL] [Abstract][Full Text] [Related]
39. [Anatomopathological tools for screening and medical surveillance of people exposed to asbestos]. Galateau-Salle F Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1244-56. PubMed ID: 10897845 [TBL] [Abstract][Full Text] [Related]
40. [Social impact of screening and of medical surveillance on people exposed to asbestos]. Bergeret A; Terrasson De Fougères G Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1327-31. PubMed ID: 10897854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]